Therapy Areas: Diabetes
Daiichi Sankyo data highlight real-world impact of bempedoic acid on cardiovascular risk
28 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) said on Friday that new analyses from the multinational MILOS study demonstrate the real-world impact of bempedoic acid, u...
Nippon Kinzoku begins mass production of ultra-thin stainless steel for insulin needles
26 August 2026 - Japanese stainless steel products manufacturer Nippon Kinzoku Co Ltd (TOKYO:5491) announced on Wednesday that it has begun mass production of ultra-thin, narrow-width stainless steel ...
Hanmi Pharm enters exclusive licensing deal with Genentech for obesity therapy HM17321
24 August 2026 - South Korean pharmaceutical company Hanmi Pharm Co Ltd announced on Monday that it has entered into an exclusive licensing agreement with Genentech, a member of the Roche Group (SIX: ...
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV
20 August 2026 - Clinical stage biotechnology company Annexin Pharmaceuticals AB (FN STO:ANNX) said on Thursday that the World Health Organization (WHO) has selected vanexin as the proposed Internatio...
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
19 August 2026 - Aqua Medical Inc, a clinical-stage medical technology company advancing Endoscopic Metabolic Restoration, announced on Tuesday the treatment of the first West Coast patient (second ov...
Kodiak Sciences enrols first patients in KSI-501 Phase 3 ALTO trial in patients with diabetic macular oedema
11 August 2026 - Kodiak Sciences Inc (Nasdaq:KOD), a precommercial retina-focused biotechnology company, announced on Monday that the first patients have been enrolled in the global Phase 3 ALTO trial...